Seeking Alpha

Valeant Pharmaceuticals (VRX +0.1%) and DepoMed (DEPO +3.0%) sue Watson Pharmaceuticals (WPI...

Valeant Pharmaceuticals (VRX +0.1%) and DepoMed (DEPO +3.0%) sue Watson Pharmaceuticals (WPI +0.2%) over its generic glumetza diabetes drug, according to reports. Sales of Glumetza are tipped to reach more than $100M this year.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs